Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) 56.3% HIGHER; today reported proof of concept data from the preliminary results of its phase 1b clinical trial of ACH-1625, demonstrating that treatment with ACH-1625 achieved a mean 3.94 log10 reduction in HCV RNA after five-day monotherapy, with continued good safety and tolerability in patients with hepatitis C.
ACH-1625 is an inhibitor of HCV NS3 protease that was discovered and is being developed by Achillion. Click here for the full report.
Helicos BioSciences Corporation...
After-Hours Movers 5/11: NLST, ACHN, ICLK, SMTX, STV...
Netlist Inc. (Nasdaq: NLST) 16.1% HIGHER; reports Q1 loss of $0.14, versus ($0.19) reported for the same period a year ago. Revenue for the quarter was $7.9 million, compared to $2.2 million...
Morning Movers 12/16: ACHN, EONC, YRCW, DPTR, EMKR...
Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) 62.8% HIGHER; today reported proof of concept data from the preliminary results of its phase 1b clinical trial of ACH-1625, demonstrating that...
Morning Movers 02/07: (SATC) (BMTI) (CSTR) (MNI)...
Satcon Technology Corporation (NASDAQ: SATC) 24.3% HIGHER; announced a partnership with Great Wall Computer Company Limited. The partnership will position Satcon to capitalize on the...
HP No. 45 Black Inkjet Print Cartridge (51645A)
Black Ink Cartridge for Hewlett Packard printers and other designated machines
Green Laser Pointer II
No, it's not red - it's green Okay, just about everyone has a red laser pointer. Heck, we even sell a fine one here at ThinkGeek. But, we're pretty sure you want to be a superior geek - and...
Post new comment